<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">3114</item><item key="factors"><item><item key="GSE13906GSM349848"><item key="disease state">normal</item><item key="cell type">gamma delta T cell</item></item></item><item><item key="GSE13906GSM349848"><item key="disease state">normal</item><item key="cell type">gamma delta T cell</item></item></item><item><item key="GSE13906GSM349850"><item key="disease state">nasal T cell lymphoma</item><item key="cell type">gamma delta T cell</item></item></item><item><item key="GSE13906GSM349850"><item key="disease state">nasal T cell lymphoma</item><item key="cell type">gamma delta T cell</item></item></item><item><item key="GSE13906GSM349852"><item key="disease state">chronic active Epstein-Barr virus infection</item><item key="cell type">gamma delta T cell</item></item></item><item><item key="GSE13906GSM349852"><item key="disease state">chronic active Epstein-Barr virus infection</item><item key="cell type">gamma delta T cell</item></item></item><item><item key="GSE13906GSM349852"><item key="disease state">chronic active Epstein-Barr virus infection</item><item key="cell type">gamma delta T cell</item></item></item><item><item key="GSE13906GSM349852"><item key="disease state">chronic active Epstein-Barr virus infection</item><item key="cell type">gamma delta T cell</item></item></item><item><item key="GSE13906GSM349856"><item key="disease state">normal</item><item key="cell type">lymphocyte</item></item></item><item><item key="GSE13906GSM349856"><item key="disease state">normal</item><item key="cell type">lymphocyte</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">The contribution of chronic antigen stimulation to the occurrence of lymphoproliferative disorder (LPD) with the gamma-delta T-cell...</item><item key="pubmed_id">20132662</item><item key="geo_gse_id">E-GEOD-13906</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">10</item><item key="tags"><item>cancer</item><item>cell</item><item>ebv infection</item><item>genome</item><item>lymphoma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcription-profiling-of-human-nk-cell-associate</item><item key="geo_id_plat">E-GEOD-13906_A-AFFY-44</item><item key="name">Transcription profiling of human NK-cell associated receptors expression in EBV-positive gamma-delta T cell lines.</item><item key="created">Sep.11, 2014</item><item key="summary">The contribution of chronic antigen stimulation to the occurrence of lymphoproliferative disorder (LPD) with the gamma-delta T-cell lineage is unclear, despite the fact that Epstein-Barr virus (EBV) positive T-cell LPD is derived from antigen-stimulated cytotoxic T-cells. Given the possible association of antigen stimulation with the development of cytotoxic T-cell LPD, we compared gene expression patterns in Epstein-Barr virus (EBV)-positive gamma-delta T-cell lines derived from patients with nasal T-cell lymphoma and chronic active EBV infection and those in gamma-delta T-cells from healthy volunteers. Three EBV-positive gamma-delta T-cells lines, SNT cells (SNT-8, SNT-13 and SNT-15), were used in this study. SNT-8 was established from patients with nasal T-cell lymphoma and SNT-13, -15 were established from patients with chronic active EBV infection (Zhang Y, et al., Br J Cancer 94:599-608, 2006). All the SNT cells exhibits common rearrangement of Vgamma9-JgammaP and Jdelta3 genes. The gamma-delta T-cells obtained from healthy volunteers were expanded ex vivo by 1 microM of zoledronate (ZOL) plus IL-2 for 14 days incubation. Experiment Overall Design: We compared gene expression profiling in 3 EBV-positive positive gamma-delta T-cells lines with those in gamma-delta T cells obtaied from a healthy volunteer.  Global gene expression was analyzed using the Affymetrix Human Genome U133 2.0 Plus GeneChip Set. Analysis of variance (ANOVA) was done using GeneSifter&#174; (VizXLabs). Values of P&lt;0.05 were considered to be a statistically significant difference.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-13906</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-13906/samples/</item></data></biogps>
